摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methylpiperidin-4-yl 4-iodobenzoate | 102698-62-4

中文名称
——
中文别名
——
英文名称
N-methylpiperidin-4-yl 4-iodobenzoate
英文别名
1-Methylpiperidin-4-yl 4-iodobenzoate;(1-methylpiperidin-4-yl) 4-iodobenzoate
N-methylpiperidin-4-yl 4-iodobenzoate化学式
CAS
102698-62-4
化学式
C13H16INO2
mdl
——
分子量
345.18
InChiKey
KRVXRNGJVZIXHS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险性防范说明:
    P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313
  • 危险性描述:
    H315,H319

反应信息

  • 作为反应物:
    描述:
    N-methylpiperidin-4-yl 4-iodobenzoate盐酸 作用下, 以 乙醚 为溶剂, 生成 4-Iodo-benzoic acid 1-methyl-piperidin-4-yl ester; hydrochloride
    参考文献:
    名称:
    一种有效评估阿尔茨海默病底物胆碱酯酶成像探针的方法
    摘要:
     抽象的 胆碱酯酶 (ChE) 已被确定为阿尔茨海默病 (AD) 的诊断标志物。已合成基于底物的探针来检测 ChE,但尚未检测到与 AD 病理相关的 ChE 分布变化。通常使用分光光度法和纯酶来筛选探针的特异性和动力学。然而,与 AD 病理相关的 ChE 的生化特性发生了改变。目前的工作是确定卡诺夫斯基根 (KR) 组织化学方法是否可用于评估病理部位的探针。合成了 30 种硫酯和酯,并使用酶动力学和 KR 方法进行了评估。分光光度法证明所有硫酯都是 ChE 底物,但只有少数硫酯通过 KR 方法在大脑中提供染色。酯是与脑 ChE 相互作用的 ChE 底物。这些结果表明 KR 方法可能提供一种有效的方法来筛选化合物作为 AD 相关 ChE 成像的探针。
    DOI:
    10.1080/14756366.2023.2225797
  • 作为产物:
    描述:
    N-甲基-4-哌啶酮 在 sodium tetrahydroborate 、 三乙胺 作用下, 以 异丙醇 为溶剂, 反应 72.0h, 生成 N-methylpiperidin-4-yl 4-iodobenzoate
    参考文献:
    名称:
    在多巴胺转运蛋白上的托烷和哌啶的4'-碘苯甲酸酯的合成和配体结合研究。
    摘要:
    合成了被设计为有效可卡因拮抗剂的可卡因的四个类似物和两个同源物。芽子碱甲酯(13)或适当取代的哌啶醇(19、21)与适当取代的4-碘苯甲酰氯之间的SN2反应得到托烷和哌啶的4-碘苯甲酸酯(5-8)。从2'-乙酰氧基可卡因(12)通过用干燥的HCl气体饱和的MeOH进行选择性酯交换反应,可以从2'-乙酰氧基可卡因(12)获得2'-羟基可卡因(9)。由乙酰水杨酰氯(23)和芽子碱甲酯(13)合成2'-乙酰氧基可卡因(12)。在多巴胺转运蛋白上测定这些化合物对[3H] WIN-35428的置换的结合亲和力。可卡因4'位置的碘基取代会降低多巴胺转运蛋白的结合力,而2'处的羟基或乙酰氧基会降低 与可卡因相比,β-位对多巴胺转运蛋白的结合力增强(分别是可卡因的10倍和3.58倍)。2'-羟基化还使4'-碘多卡因(5)的出价能力提高了10倍。用哌啶取代托烷环导致较差的结合亲和力。
    DOI:
    10.1021/jm970121i
点击查看最新优质反应信息

文献信息

  • BUTYRYLCHOLINESTERASE LIGANDS AS DIAGNOSTIC TOOLS AND TREATMENT FOR DESEASES OF THE NERVOUS SYSTEM
    申请人:Darvesh Sultan
    公开号:US20110212026A1
    公开(公告)日:2011-09-01
    Compounds useful for the early diagnosis of malignant tumors, multiple sclerosis, and especially Alzheimer's Disease and related dementias; especially compounds of Formula (I) wherein R 1 is selected from the group consisting of hydrogen, cyano, fluoro, iodo, alkyl, and aryl; R 2 is selected from the group consisting of hydrogen, alkyl, and aryl; X is selected from the group consisting of CH 2 , CH 2 O, oxygen, OCH 2 , CH 2 S, SCH 2 , NH, N-alkyl, and N-aryl; Y is an optional spacer group, absent or selected from the group consisting of oxygen, sulfur, NH, N-alkyl, and N-aryl; and Z is selected from the group consisting of alkyl substituted with cyano, fluoro, or iodo and aryl substituted with cyano, fluoro, or iodo. In a preferred embodiment, R 1 and R 2 are hydrogen, X is CH 2 O, Y is absent, and Z is phenyl substituted with fluoro, cyano, or iodo. In some embodiments, Z is more specifically 18 F-phenyl or 123 I-phenyl or 131 I-phenyl. Other compounds are also provided.
    本发明提供了用于早期诊断恶性肿瘤、多发性硬化症,尤其是阿尔茨海默病和相关痴呆症的化合物,特别是式(I)的化合物,其中R1选自氢、氰、氟、碘、烷基和芳基组成的群体;R2选自氢、烷基和芳基组成的群体;X选自CH2、CH2O、氧、OCH2、CH2S、SCH2、NH、N-烷基和N-芳基组成的群体;Y是可选的间隔基团,不存在或选自氧、硫、NH、N-烷基和N-芳基组成的群体;Z选自用氰、氟或碘取代的烷基和用氰、氟或碘取代的芳基组成的群体。在首选实施例中,R1和R2为氢,X为CH2O,Y不存在,Z为用氟、氰或碘取代的苯基。在某些实施例中,Z更具体地为18F-苯基或123I-苯基或131I-苯基。本发明还提供了其他化合物。
  • Thioesters for the <i>in vitro</i> evaluation of agents to image brain cholinesterases
    作者:Ian R. Macdonald、Courtney T. Jollymore、G. Andrew Reid、Ian R. Pottie、Earl Martin、Sultan Darvesh
    DOI:10.3109/14756366.2011.647008
    日期:2013.6.1
    Cholinesterases are associated with pathology characteristic of conditions such as Alzheimer's disease and are therefore, considered targets for neuroimaging. Ester derivatives of N-methylpiperidinol are promising potential imaging agents; however, methodology is lacking for evaluating these compounds in vitro. Here, we report the synthesis and evaluation of a series of N-methylpiperidinyl thioesters, possessing comparable properties to their corresponding esters, which can be directly evaluated for cholinesterase kinetics and histochemical distribution in human brain tissue. N-methylpiperidinyl esters and thioesters were synthesized and they demonstrated comparable cholinesterase kinetics. Furthermore, thioesters were capable, using histochemical method, to visualize cholinesterase activity in human brain tissue. N-methylpiperidinyl thioesters can be rapidly evaluated for cholinesterase kinetics and visualization of enzyme distribution in brain tissue which may facilitate development of cholinesterase imaging agents for application to conditions such as Alzheimer's disease.
  • US8795630B2
    申请人:——
    公开号:US8795630B2
    公开(公告)日:2014-08-05
  • [EN] BUTYRYLCHOLINESTERASE LIGANDS AS DIAGNOSTIC TOOLS AND TREATMENT FOR DESEASES OF THE NERVOUS SYSTEM<br/>[FR] LIGANDS DE LA BUTYRYLCHOLINESTÉRASE EN TANT QU'OUTILS DE DIAGNOSTIC ET DE TRAITEMENT DES PATHOLOGIES DU SYSTÈME NERVEUX
    申请人:TREVENTIS CORP
    公开号:WO2010025368A1
    公开(公告)日:2010-03-04
    Compounds useful for the early diagnosis of malignant tumors, multiple sclerosis, and especially Alzheimer's Disease and related dementias; especially compounds of Formula (I) wherein R1 is selected from the group consisting of hydrogen, cyano, fluoro, iodo, alkyl, and aryl; R2 is selected from the group consisting of hydrogen, alkyl, and aryl; X is selected from the group consisting of CH2, CH2O, oxygen, OCH2, CH2S, SCH2, NH, N-alkyl, and N-aryl; Y is an optional spacer group, absent or selected from the group consisting of oxygen, sulfur, NH, N-alkyl, and N-aryl; and Z is selected from the group consisting of alkyl substituted with cyano, fluoro, or iodo and aryl substituted with cyano, fluoro, or iodo. In a preferred embodiment, R1 and R2 are hydrogen, X is CH2O, Y is absent, and Z is phenyl substituted with fluoro, cyano, or iodo. In some embodiments, Z is more specifically 18F-phenyl or 123I-phenyl or 131I-phenyl. Other compounds are also provided.
  • Synthesis and Ligand Binding Studies of 4‘-Iodobenzoyl Esters of Tropanes and Piperidines at the Dopamine Transporter
    作者:Satendra Singh、Garo P. Basmadjian、Kwasi S. Avor、Buddy Pouw、Thomas W. Seale
    DOI:10.1021/jm970121i
    日期:1997.8.1
    group substitution at the 4'-position of cocaine decreased dopamine transporter binding potency, while a hydroxy or acetoxy group at the 2'-position exhibited increased binding potency for the dopamine transporter compared to cocaine (10- and 3.58-fold, respectively). 2'-Hydroxylation also enhanced the bidning potency of 4'-iodococaine (5) by 10-fold. Replacement of the tropane ring with piperidine led
    合成了被设计为有效可卡因拮抗剂的可卡因的四个类似物和两个同源物。芽子碱甲酯(13)或适当取代的哌啶醇(19、21)与适当取代的4-碘苯甲酰氯之间的SN2反应得到托烷和哌啶的4-碘苯甲酸酯(5-8)。从2'-乙酰氧基可卡因(12)通过用干燥的HCl气体饱和的MeOH进行选择性酯交换反应,可以从2'-乙酰氧基可卡因(12)获得2'-羟基可卡因(9)。由乙酰水杨酰氯(23)和芽子碱甲酯(13)合成2'-乙酰氧基可卡因(12)。在多巴胺转运蛋白上测定这些化合物对[3H] WIN-35428的置换的结合亲和力。可卡因4'位置的碘基取代会降低多巴胺转运蛋白的结合力,而2'处的羟基或乙酰氧基会降低 与可卡因相比,β-位对多巴胺转运蛋白的结合力增强(分别是可卡因的10倍和3.58倍)。2'-羟基化还使4'-碘多卡因(5)的出价能力提高了10倍。用哌啶取代托烷环导致较差的结合亲和力。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐